Long-term rate of heart failure in patients with autoimmune disease: A nationwide cohort study

Atrial FibrillationHeart Failure

Long-term risk of heart failure in patients with postoperative atrial fibrillation following non-cardiac surgery: Insights from a nationwide cohort

Eur J Heart Fail

Karacan MN, Yafasova A, Fosbøl EL, Tas A, Al-Chaer K, Gundlund A, Gustafsson F, Stahl A, Schou M, Wolsk E, Dridi NP, Køber L, Butt JH

doi: 10.1002/ejhf.3518

Cardiac Arrest or DeathMyocardial Infarction

Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: A nationwide cohort study 2013-2022

Eur Heart J Acute Cardiovasc Care

Jortveit J, Andersen GØ, Halvorsen S

doi: 10.1093/ehjacc/zuae121

Heart Failure

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

ESC Heart Fail

Berry NC, Sheu YS, Chesbrough K, Bishop RC, Vupputuri S

doi: 10.1002/ehf2.15193

Heart Failure

Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

J Rheumatol

Koppikar S, Kuriya B, Udell JA, Yu B, Chu A, Lee DS, Widdifield J, Eder L

doi: 10.3899/jrheum.2024-0866

Heart Failure

Heart failure in patients with congenital heart disease after a cancer diagnosis

ESC Heart Fail

Karazisi C, Dellborg M, Mellgren K, Giang KW, Skoglund K, Eriksson P, Mandalenakis Z

doi: 10.1002/ehf2.14945

Heart Failure

Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure

Eur J Heart Fail

Averbuch T, Lee SF, Zagorski B, Pandey A, Petrie MC, Biering-Sorensen T, Xie F, Van Spall HGC

doi: 10.1002/ejhf.3499

Heart Failure

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

ESC Heart Fail

Kocabas U, Ergin I, Yavuz V, Altın C, Kaplan M, Yılmaz Öztekin GM, Doğduş M, Murat S, Murat B, Kıvrak T, Karabulut D, Kaya E, Özdemir İH, Yıldız C, Salkın FÖ, Özçalık E, Polatkan ŞG, Çakan F, Şen T, Karabulut U, Çakal S, Oflar E, Sinan ÜY, Yenerçağ M, Türk UÖ

doi: 10.1002/ehf2.15049

Atrial FibrillationHeart Failure

Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

Circ Arrhythm Electrophysiol

Xing LY, Højberg S, Krieger DW, Graff C, Olesen MS, Healey JS, McIntyre WF, Brandes A, Køber L, Haugan KJ, Svendsen JH, Diederichsen SZ

doi: 10.1161/CIRCEP.124.012764

Heart Failure

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study

Clin Res Cardiol

Ojeda-Fernández L, Torrigiani G, Molteni M, Fortino I, Cimminiello C, Baviera M

doi: 10.1007/s00392-025-02674-9

Related content

Long-term risk of heart failure in patients with postoperative atrial fibrillation following non-cardiac surgery: Insights from a nationwide cohort

Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: A nationwide cohort study 2013-2022

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

Heart failure in patients with congenital heart disease after a cancer diagnosis

Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study